About Travel Vaccines Vaccines are biological preparations that provide immunity to a particular disease by stimulating the immune system. The vaccines can be administered orally, intra-nasally, or through injections in both adults and children. Government bodies such as the CDC and the NHS have mandated the vaccination of emigrants traveling to disease-prone areas to prevent the spread of infectious agents through them.
TechNavio's analysts forecast the Global Travel Vaccines market to grow at a CAGR of 7.78 percent over the period 2014-2019.
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/38621-global-travel-vaccines-market-2015-2019
Covered in this Report Based on composition, the Global Travel Vaccines market is divided into two segments: Mono Vaccines and Combination Vaccines. This report covers the present scenario and the growth prospects of the Global Travel Vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sale of various vaccines administered to actively immunize against meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A.
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Travel Vaccines market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio's report, Global Travel Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Travel Vaccines market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions • Americas
• APAC
• EMEA
Key Vendors • GlaxoSmithKline
• Merck & Co.
• Novartis
• Sanofi
• APAC
• EMEA
Key Vendors • GlaxoSmithKline
• Merck & Co.
• Novartis
• Sanofi
Other Prominent Vendors • Beijing Minhai Biotechnology
• Bharat Biotech
• Bio Med
• Crucell
• CSL
• Dynavax Technologies
• Emergent Biosolutions
• Green Signal Bio Pharma
• Hualan Biological Engineering
• Imunoloski Zavod
• Indian Immunologicals
• Janssen Pharmaceuticals
• JN International Medical
• Kaketsuken
• LG Life Sciences
• Novavax
• Nuron Biotech
• Panacea Biotec
• Pfizer
• S K Chemicals
• Serum Institute of India
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• Vacunas Finlay
• Valneva
• Bharat Biotech
• Bio Med
• Crucell
• CSL
• Dynavax Technologies
• Emergent Biosolutions
• Green Signal Bio Pharma
• Hualan Biological Engineering
• Imunoloski Zavod
• Indian Immunologicals
• Janssen Pharmaceuticals
• JN International Medical
• Kaketsuken
• LG Life Sciences
• Novavax
• Nuron Biotech
• Panacea Biotec
• Pfizer
• S K Chemicals
• Serum Institute of India
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• Vacunas Finlay
• Valneva
Market Driver • Growing Demand among Travelers
• For a full, detailed list, view our report
• For a full, detailed list, view our report
Market Challenge • Cold Chain Management
• For a full, detailed list, view our report
• For a full, detailed list, view our report
Market Trend • Increased Awareness.
• For a full, detailed list, view our report
• For a full, detailed list, view our report
Key Questions Answered in this Report • What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Complete Report Details @ https://www.wiseguyreports.com/reports/38621-global-travel-vaccines-market-2015-2019
Table of Contents
- Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Vaccine Approval Process
07. Late-stage Pipeline Candidates
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Global Hepatitis A Vaccines Market
08.3.1 Market Size and Forecast
08.4 Five Forces Analysis
09. Market Segmentation by Composition
09.1 Mono Vaccine
09.1.1 Polysaccharide Vaccines
09.1.2 Conjugate Vaccines
09.2 Combination Vaccines
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 SWOT Analysis: Global Travel Vaccines Market
18.2.2 GlaxoSmithKline
18.2.3 Merck
18.2.4 Novartis
18.2.5 Sanofi
18.3 Other and Future Prominent Vendors
19. Key Vendor Analysis
19.1 GlaxoSmithKline 19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Sales by Geography
19.1.6 Pipeline Products
19.1.7 Business Strategy
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Merck 19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation by Revenue 2013
19.2.4 Business Segmentation by Revenue 2012 and 2013
19.2.5 Sales by Geography
19.2.6 Business Strategy
19.2.7 Key Developments
19.2.8 SWOT Analysis
19.3 Novartis 19.3.1 Key Facts
19.3.2 Business Description
19.3.3 Business Segmentation
19.3.4 Revenue by Business Segmentation
19.3.5 Revenue Comparison 2012 and 2013
19.3.6 Sales by Geography
19.3.7 Business Strategy
19.3.8 Key Developments
19.3.9 SWOT Analysis
19.4 Sanofi 19.4.1 Key Facts
19.4.2 Business Description
19.4.3 Business Segmentation
19.4.4 Revenue by Business Segmentation
19.4.5 Revenue Comparison 2012 and 2013
19.4.6 Sales by Geography
19.4.7 Business Strategy
19.4.8 Key Developments
19.4.9 SWOT Analysis
20. Other Reports in this Series
Continued…….
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
sales@wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment